These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


143 related items for PubMed ID: 12482

  • 1. Dopaminergic neurons: reversal of effects elicited by gamma-butyrolactone by stimulation of the nigro-neostriatal pathway.
    Murrin LC, Roth RH.
    Naunyn Schmiedebergs Arch Pharmacol; 1976 Oct; 295(1):15-20. PubMed ID: 12482
    [Abstract] [Full Text] [Related]

  • 2. Central dopaminergic neurons: effects of alterations in impulse flow on the accumulation of dihydroxyphenylacetic acid.
    Roth RH, Murrin LC, Walters JR.
    Eur J Pharmacol; 1976 Mar; 36(1):163-71. PubMed ID: 177297
    [Abstract] [Full Text] [Related]

  • 3. Effects of severe dopamine depletion on dopamine neuronal impulse flow and on tyrosine hydroxylase regulation.
    German DC, McMillen BA, Sanghera MK, Saffer SI, Shore PA.
    Brain Res Bull; 1981 Feb; 6(2):131-4. PubMed ID: 6110470
    [Abstract] [Full Text] [Related]

  • 4. Increased site-specific phosphorylation of tyrosine hydroxylase accompanies stimulation of enzymatic activity induced by cessation of dopamine neuronal activity.
    Lew JY, Garcia-Espana A, Lee KY, Carr KD, Goldstein M, Haycock JW, Meller E.
    Mol Pharmacol; 1999 Feb; 55(2):202-9. PubMed ID: 9927609
    [Abstract] [Full Text] [Related]

  • 5. Chronic intranigral administration of brain-derived neurotrophic factor produces striatal dopaminergic hypofunction in unlesioned adult rats and fails to attenuate the decline of striatal dopaminergic function following medial forebrain bundle transection.
    Lapchak PA, Beck KD, Araujo DM, Irwin I, Langston JW, Hefti F.
    Neuroscience; 1993 Apr; 53(3):639-50. PubMed ID: 8098137
    [Abstract] [Full Text] [Related]

  • 6. Serotonin agonists reduce dopamine synthesis in the striatum only when the impulse flow of nigro-striatal neurons is intact.
    Spampinato U, Esposito E, Samanin R.
    J Neurochem; 1985 Sep; 45(3):980-2. PubMed ID: 3928812
    [Abstract] [Full Text] [Related]

  • 7. Acceleration of the biosynthesis of rat striatal dopamine by incubation and by administration of gamma-butyrolactone.
    Dyck LE, Kazakoff CW.
    J Neurosci Res; 1982 Sep; 8(1):57-65. PubMed ID: 7175978
    [Abstract] [Full Text] [Related]

  • 8. Presynaptic inhibition of nigrostriatal dopamine release in the mouse: lack of cross tolerance between apomorphine, GBL and CGS 10746B.
    Wood PL, Altar CA, Kim HS.
    Life Sci; 1988 Sep; 42(16):1503-6. PubMed ID: 3352463
    [Abstract] [Full Text] [Related]

  • 9. Nigrostriatal dopamine neurons: modulation of impulse-induced activation of tyrosine hydroxylation by dopamine autoreceptors.
    Murrin LC, Roth RH.
    Neuropharmacology; 1987 Jun; 26(6):591-5. PubMed ID: 2885775
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Chronic gamma-butyrolactone (GBL) treatment: a potential model of dopamine hypoactivity.
    Nowycky MC, Roth RH.
    Naunyn Schmiedebergs Arch Pharmacol; 1979 Nov; 309(3):247-54. PubMed ID: 43476
    [No Abstract] [Full Text] [Related]

  • 12. Sensorimotor impairment and elevated levels of dopamine metabolites in the neostriatum occur rapidly after intranigral injection of 6-hydroxydopamine or gamma-hydroxybutyrate in awake rats.
    Altar CA, O'Neil S, Marshall JF.
    Neuropharmacology; 1984 Mar; 23(3):309-18. PubMed ID: 6427648
    [Abstract] [Full Text] [Related]

  • 13. Delayed inhibition of dopamine synthesis by gamma-butyrolactone and baclofen: dopamine autoreceptor supersensitivity?
    Argiolas A, Fadda F, Melis MR, Marcou M, Porceddu ML, Gessa GL.
    Eur J Pharmacol; 1982 Nov 05; 85(1):23-7. PubMed ID: 6818043
    [Abstract] [Full Text] [Related]

  • 14. An investigation of the relationship between the dopaminergic and electroencephalographic effects of gamma-butyrolactone.
    Snead OC.
    Neuropharmacology; 1982 Jun 05; 21(6):539-43. PubMed ID: 7110537
    [Abstract] [Full Text] [Related]

  • 15. Regulation of the synthesis and metabolism of striatal dopamine after disruption of nerve conduction in the medial forebrain bundle.
    Commissiong JW, Slimovitch C, Toffano G.
    Br J Pharmacol; 1990 Apr 05; 99(4):741-9. PubMed ID: 2361171
    [Abstract] [Full Text] [Related]

  • 16. The vigilance-promoting drug modafinil counteracts the reduction of tyrosine hydroxylase immunoreactivity and of dopamine stores in nigrostriatal dopamine neurons in the male rat after a partial transection of the dopamine pathway.
    Ueki A, Rosén L, Andbjer B, Finnman UB, Altamimi U, Janson AM, Goldstein M, Agnati LF, Fuxe K.
    Exp Brain Res; 1993 Apr 05; 93(2):259-70. PubMed ID: 8098283
    [Abstract] [Full Text] [Related]

  • 17. Rotational behavior induced by unilateral electrical stimulations of nigro-striatal dopamine neurons: modification by low doses of apomorphine.
    Barghon R, Costentin JH.
    Eur J Pharmacol; 1980 May 30; 64(1):39-46. PubMed ID: 6969658
    [Abstract] [Full Text] [Related]

  • 18. Electrical stimulation of the substantia nigra and changes of 2-phenylethylamine synthesis in the rat striatum.
    Juorio AV, Paterson IA, Zhu MY, Matte G.
    J Neurochem; 1991 Jan 30; 56(1):213-20. PubMed ID: 1670953
    [Abstract] [Full Text] [Related]

  • 19. Role of dopamine storage function in the control of rat striatal tyrosine hydroxylase activity.
    McMillen BA, Shore PA.
    Naunyn Schmiedebergs Arch Pharmacol; 1980 Aug 30; 313(1):39-44. PubMed ID: 6111026
    [Abstract] [Full Text] [Related]

  • 20. Stimulus-evoked changes in neostriatal dopamine levels in awake and anesthetized rats as measured by microdialysis.
    Tepper JM, Creese I, Schwartz DH.
    Brain Res; 1991 Sep 20; 559(2):283-92. PubMed ID: 1794102
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 8.